• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Public Health . Sociodemographic characteristics of SARS-CoV-2 serosurveillance studies with diverse recruitment strategies, Canada, 2020 to 20

tetano

Editor, Senior Moderator
BMC Public Health


. 2025 Jun 3;25(1):2057.
doi: 10.1186/s12889-025-22975-y. Sociodemographic characteristics of SARS-CoV-2 serosurveillance studies with diverse recruitment strategies, Canada, 2020 to 2023

Matthew J Knight[SUP] 1 [/SUP], Yuan Yu[SUP] 2 [/SUP], Jiacheng Chen[SUP] 2 [/SUP], Sheila F O'Brien[SUP] 3 4 [/SUP], David L Buckeridge[SUP] 2 5 [/SUP], Carmen Charlton[SUP] 6 7 [/SUP], W Alton Russell[SUP] 2 5 [/SUP]



Affiliations
Free article Abstract

Background: Serological testing was a key component of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) surveillance. Social distancing interventions, resource limitations, and the need for timely data led to serosurveillance studies using a range of recruitment strategies, which likely influenced study representativeness. Characterizing representativeness in surveillance is crucial to identify gaps in sampling coverage and to assess health inequities.
Methods: We retrospectively analyzed three pre-existing longitudinal cohorts, two convenience samples using residual blood, and one de novo probabilistic survey conducted in Canada between April 2020 - November 2023. We calculated study specimen counts by age, sex, urbanicity, race/ethnicity, and neighborhood deprivation quintiles. We derived a 'representation ratio' as a simple metric to assess generalizability to a target population and various sociodemographic strata.
Results: The six studies included 1,327,142 specimens. When stratifying by age group and sex, 67% of racialized minority subgroups were moderately underrepresented (representation ratio < 0.75). Representation was generally higher for older Canadians, urban neighborhoods, and neighborhoods with low material deprivation. Rural representation was highest in a study that used outpatient laboratory blood specimens. Racialized minority representation was highest in a de novo probabilistic survey cohort and an open longitudinal cohort recruited from an online polling panel.
Conclusion: While no study had adequate representation of all subgroups, less traditional recruitment strategies were more representative of some population dimensions. Understanding demographic representativeness and barriers to recruitment are important considerations when designing population health surveillance studies.

Keywords: COVID-19; Representativeness; Surveillance.

 
Back
Top Bottom